89532-43-4 Usage
Uses
Used in Pharmaceutical Industry:
3-(1H-pyrazol-1-yl)propanal serves as an intermediate in the synthesis of a variety of organic compounds and pharmaceuticals. Its unique structure allows it to be a valuable building block in creating new medications with specific therapeutic targets.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-(1H-pyrazol-1-yl)propanal is utilized for its potential anti-inflammatory, analgesic, and antimicrobial properties. Researchers are interested in exploring these properties to develop new treatments for various conditions.
Used in Drug Development:
3-(1H-pyrazol-1-yl)propanal is also being studied for its potential as a therapeutic agent in the treatment of certain diseases and medical conditions. Its diverse applications make it a promising candidate for further research and development in drug discovery.
Safety Precautions:
As with any chemical compound, it is crucial to follow proper handling and safety precautions when working with 3-(1H-pyrazol-1-yl)propanal to ensure the safety of researchers and the integrity of the experiments.
Check Digit Verification of cas no
The CAS Registry Mumber 89532-43-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,9,5,3 and 2 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 89532-43:
(7*8)+(6*9)+(5*5)+(4*3)+(3*2)+(2*4)+(1*3)=164
164 % 10 = 4
So 89532-43-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H8N2O/c9-6-2-5-8-4-1-3-7-8/h1,3-4,6H,2,5H2
89532-43-4Relevant academic research and scientific papers
TETRAHYDRO-IMIDAZO QUINOLINE COMPOSITIONS AS CBP/P300 INHIBITORS
-
Paragraph 0098-0099, (2019/04/11)
The present disclosure is directed to inhibitors of the CBP/p300 family of bromodomains. The compounds can be useful in the treatment of disease or disorders associated with the inhibition of the CBP/p300 family of bromodomains. For instance, the disclosure is concerned with compounds and compositions for inhibition of the CBP/p300 family of bromodomains, methods of treating, preventing, or ameliorating diseases or disorders associated with the inhibition of CBP/p300 family of bromodomains, and methods of synthesis of these compounds.
Hafnium chloride catalyzed conjugate addition of pyrrole, pyrazole and imidazole to α,β-unsaturated ketones
Aburatani, Sachiko,Kawatsura, Motoi,Uenishi, Jun'ichi
, p. 189 - 196 (2008/02/02)
Pyrrole, pyrazole and imidazole undergo conjugate addition with α,β-unsaturated ketones in the presence of a catalytic amount of hafnium chloride at room temperature. Although the reaction of pyrrole gave 2,5-substituted C-adduct mainly, those of pyrazole
Catalytic conjugate addition of heterocyclic compounds to α,β-unsaturated carbonyl compounds by hafnium salts and scandium salts
Kawatsura, Motoi,Aburatani, Sachiko,Uenishi, Junichi
, p. 4172 - 4177 (2008/01/08)
The hafnium chloride (HfCl4) and scandium chloride (ScCl3) catalyzed conjugate additions of heterocyclic compounds, such as indoles, pyrrole, pyrazole, and imidazole, have been demonstrated. Hafnium chloride effectively catalyzed the
